fadrozole has been researched along with Atherosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coleman, R; Gamliel-Lazarovich, A; Gantman, A; Jeng, AY; Kaplan, M; Keidar, S | 1 |
1 other study(ies) available for fadrozole and Atherosclerosis
Article | Year |
---|---|
FAD286, an aldosterone synthase inhibitor, reduced atherosclerosis and inflammation in apolipoprotein E-deficient mice.
Topics: Aldosterone; Animals; Apolipoproteins E; Atherosclerosis; Cell Line; Cytochrome P-450 CYP11B2; Diet, Sodium-Restricted; Enzyme Inhibitors; Fadrozole; Imidazoles; Inflammation; Macrophages; Male; Mice; Mice, Knockout; Pyridines | 2010 |